Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
EnBio Holdings's 10-Year RORE % for the quarter that ended in Mar. 2026 was 5.54%.
The industry rank for EnBio Holdings's 10-Year RORE % or its related term are showing as below:
TSE:6092's 10-Year RORE % is ranked worse than 55.97% of 611
companies
in the Business Services industry
Industry Median: 7.76
vs TSE:6092: 5.54
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
EnBio Holdings 10-Year RORE % Related Terms
EnBio Holdings 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, GPN: 10-Year RORE % Comparison
For the Specialty Business Services subindustry, EnBio Holdings's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings 10-Year RORE % vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.
EnBio Holdings (TSE:6092) has a 10-Year RORE % of 5.54 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on EnBio Holdings and its competitors. According to the industry distribution chart, EnBio Holdings ranks #342 out of 611 companies in the Business Services industry, placing it in the top 56%.
Is EnBio Holdings' 10-Year RORE % too high?
EnBio Holdings' current 10-Year RORE % is 5.54. The Business Services industry median 10-Year RORE % is 7.76. EnBio Holdings' value of 5.54 is 28.6% below this industry median. Based on the distribution chart, EnBio Holdings ranks #342 out of 611 companies in the Business Services industry, which is below the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' 10-Year RORE % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #342 out of 611 companies for 10-Year RORE %. This places EnBio Holdings in the lower half of its industry. The industry median 10-Year RORE % is 7.76. EnBio Holdings' value of 5.54 is 28.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Business Services company?
The median 10-Year RORE % among Business Services companies is 7.76, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current 10-Year RORE % of 5.54 is 28.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median 10-Year RORE % is 7.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current 10-Year RORE % is 5.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円804.28, compared to a current price of 円757.00 — trading 5.9% below its estimated fair value. The current 10-Year RORE % is 5.54 and 28.6% below the Business Services industry median of 7.76. EnBio Holdings' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current 10-Year RORE % is 5.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円757.00 is trading 5.9% below its estimated GF Value™ of 円804.28.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
10-Year RORE %: 5.54
GF Value™: 円804.28 vs. price of 円757.00 (5.9% below fair value)
Industry Position: 28.6% below the Business Services median (#342 of 611)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
59GF Score
Get the complete analysis for TSE:6092
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
